drugset / Trial / NCT00522782

Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children

NCT00522782

NaSingle-groupOpen-labelTreatment

Summary

To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.

Timeline

Start
2007-08
Primary completion
2008-12
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 0.5 mg Other

Indications